Two Indian CROs under lens as United States raises data integrity issues

USFDA's action follows inspections at the facilities of Ahmedabad-based Synchron and Navi Mumbai-based Panexcell, as well as its own analyses of study data generated at these CROs and submitted in several applications.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3zHKQEA
via IFTTT